Curious to see your top suppliers emissions?
Book a demo for a pilot project
Fortovia Therapeutics, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agofortovia.com
Fortovia Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in the United States, is dedicated to advancing innovative therapies for patients with rare diseases. Founded in [year], Fortovia has established itself as a leader in the biotechnology sector, focusing on the development of cutting-edge treatments that address unmet medical needs.
With a strong emphasis on research and development, Fortovia Therapeutics is renowned for its unique approach to drug discovery, leveraging advanced technologies to create targeted therapies. The company’s core products aim to transform the treatment landscape for specific rare conditions, setting it apart in a competitive market.
Recognised for its commitment to excellence, Fortovia has achieved significant milestones, positioning itself as a key player in the biopharmaceutical industry. Its ongoing efforts to enhance patient outcomes underscore the company's dedication to innovation and quality in healthcare.
27
DitchCarbon score
-15 vs industry average
Fortovia Therapeutics, Inc.’s score of 27 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Fortovia Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Fortovia Therapeutics, Inc. yet.
Fortovia Therapeutics, Inc.'s reported carbon emissions
Fortovia Therapeutics, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, Scope 2, and Scope 3 emissions are not provided.
The company is a current subsidiary of Massachusetts Mutual Life Insurance Company, which may influence its climate commitments and reporting practices. However, there are no documented reduction targets or climate pledges from Fortovia Therapeutics, Inc. at this time.
In the context of the industry, it is essential for companies like Fortovia to establish clear climate commitments and reduction initiatives to align with global sustainability goals. As the landscape of corporate responsibility evolves, the expectation for transparency in emissions reporting and proactive climate strategies continues to grow.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Fortovia Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Fortovia Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Inherited from Massachusetts Mutual Life Insurance CompanySee details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Fortovia Therapeutics, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more